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Background
Schwannomas are rare tumors of the nerve sheath that arise
from the primary glial cells of the peripheral nervous system.
As such, schwannomas may arise from any myelinated pe-
ripheral nerve. They are generally well-circumscribed lesions
that rarely undergo malignant degeneration. Although be-
nign and slow growing, schwannomas can cause signiﬁcant
morbidity due to direct involvement of nerves or by local
mass effect that can pose particular challenges for treatment.
Approximately 25 to 45% of all schwannomas are found in
the head and neck, where they can originate from virtually
any cranial nerve.1 The most common schwannoma is the
vestibular schwannoma that arises from the vestibular
branch of the eighth cranial nerve and accounts for 51% of
all nerve sheath tumors found anywhere in the body.2 This is
followed by schwannomas of the trigeminal nerve that
comprise up to 8% of all schwannomas.3 By contrast,
schwannomas in the nasal cavity or paranasal sinuses—
and vidian canal schwannomas in particular—are much
rarer. The vidian canal, also referred to as the pterygoid
canal, extends from the pterygopalatine fossa to the fora-
men lacerum in the ﬂoor of the sphenoid sinus4 and con-
tains the vidian artery aswell as the vidian nerve. The vidian
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Abstract Background Schwannomas of the vidian canal are an extremely rare type of intracra-
nial tumor that can have variable clinical presentations including headache, facial pain,
facial muscle paralysis, decreased lacrimation, or nasal dryness. We present an atypical
case of an incidentally identiﬁed asymptomatic vidian canal schwannoma.
Case Description A 49-year-old woman with a history of multiple sclerosis presented
for routine surveillance magnetic resonance imaging that detected an ovoid mass
originating in the vidian canal. Given the unusual location of the lesion, an endoscopic
endonasal biopsy was performed and conﬁrmed the diagnosis of a vidian canal
schwannoma, for which the patient chose to receive fractionated radiation therapy.
Conclusion When a vidian canal tumor is identiﬁed, endoscopic endonasal biopsy can
be used to conﬁrm the diagnosis before pursuing either surgical or radiotherapy
treatment. In particular, fractionated radiation therapy offers a radiobiologically safe
means of delivering radiation when there is concern for late radiation-related side effects
following treatment completion.
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nerve arises from the joining of the greater superﬁcial
petrosal nerve and the deep petrosal nerve. The greater
superﬁcial petrosal nerve consists of preganglionic para-
sympathetic ﬁbers from the geniculate ganglion of the facial
nerve. The deep petrosal nerve consists of postganglionic
sympathetic ﬁbers from the carotid sympathetic plexus.5–8
The parasympathetic ﬁbers of the vidian nerve synapse in
the pterygopalatine ganglion, whereas the sympathetic
ﬁbers innervate the lacrimal gland and secretory pathways
of the nasopalatine glands.5,6
Schwannomas of the vidian canal can present with a
variety of clinical symptoms. Damage to the vidian nerve
itself can result in decreased or absent lacrimation, corneal
desiccation aswell as dryness of the nasalmucosa, and cluster
headaches.5 Additionally, vidian schwannomas have been
reported to compress the adjacent internal carotid artery or
bulge through the lateral wall of the sphenoid sinus to expand
into the cavernous sinus.6,9
To date, only 4 cases of vidian nerve schwannomas and 11
cases of histologically unconﬁrmed peri-vidian tumors have
been reported in the literature.10–15Herewe present a case of
biopsy-proven schwannoma of the vidian canal. We discuss
the patient’s initial presentation, imaging characteristics,
histologic ﬁndings, and treatment for this unusual tumor
and review the other reported cases of vidian canal schwan-
nomas in the literature.
Case History
The patient is a 49-year-old woman with a 24-year history of
multiple sclerosis (MS) who presented for follow-up evalua-
tion after an acute ﬂare of MS. In the past, her MS ﬂares had
been relatively infrequent, with motor and/or peripheral
sensory deﬁcits that were well controlled with short-term
courses of steroids. During her most recent ﬂare, she experi-
enced numbness of her left head, arm, and leg, with full
resolution of symptoms after steroid treatment. Her past
medical history was otherwise unremarkable.
A routine surveillance brain magnetic resonance imaging
(MRI) was performed to evaluate for MS progression. MRI
showed minimal progression of disease compared with
imaging from 8 years prior, with extensive T2, ﬂuid-attenu-
ated inversion recovery, and proton-density prolonged signal
in the periventricular, pericallosal, and subcortical white
matter consistent with MS. Incidentally, the MRI also re-
vealed a 19  13  10 mm ovoid mass along the inferior
margin of the right cavernous sinus that was not present on
previous MRIs. The lesion was well circumscribed and ho-
mogeneously enhancing, with T1 hypointense and T2 hyper-
intense signal. A repeat dedicated MRI was performed that
demonstrated the lesion originated within an expanded
vidian canal (►Fig. 1). A sinus computed tomography scan
also showed bony erosion of an expanded vidian canal
(►Fig. 2). From a symptom standpoint, the patient noted
some mild nasal congestion in the mornings but was other-
wise asymptomatic without any facial pain or paresthesias,
abnormal lacrimation, or dry eye symptoms. Physical exam-
ination was similarly unremarkable with a normal nasal
endoscopy and no focal neurologic deﬁcits. An endoscopic
Fig. 1 An ovoid 14  20  13-mmmass (white arrows) centered in an enlarged right vidian canal and extending along the inferior margin of the
right cavernous sinus. The mass has (A) bright T1 signal post contrast, coronal view, and (B) bright T2 signal with fat saturation. There was no
evidence of diffusion restriction (not shown).
Fig. 2 Preoperative sinus computed tomography scan without con-
trast demonstrating bony erosion of the right vidian canal (red arrow).
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endonasal biopsy was performed with image guidance. The
sphenoid ostium was identiﬁed medial to the superior
turbinate in a transethmoidal fashion. The ostium was en-
larged laterally and inferiorly, and a wide sphenoidotomy
was created. The mass was easily identiﬁed within a notice-
ably expanded vidian canal along the lateral ﬂoor of the
sphenoid sinus (►Fig. 3). The canal was opened along the
ﬂoor of the sphenoid sinus to uncover the mass and a biopsy
was obtained. The ﬁnal histopathologic assessment con-
ﬁrmed a diagnosis of schwannoma. The patient’s recovery
was unremarkable, and she had no problems with dry eye or
nasal irritation postoperatively. Twoweeks after surgery, her
endoscopic examination showed a well-healed sinus cavity.
Options of endoscopic surgical resection, single-fraction
stereotactic radiosurgery (SRS), and conventional fractionat-
ed radiotherapy using stereotactic radiotherapy (SRT) were
reviewed with the patient, and she decided to pursue treat-
ment with radiation. Given the benign histology, a back-
ground of MS that could confer additional sensitivity to
radiation, and the patient’s young age, the patient decided
to pursue SRT to minimize late normal tissue injury risks. SRT
was delivered at 1.8 Gy per fraction to 50.4 Gy. Treatment was
well tolerated; the most notable symptom was mild fatigue.
Discussion
Schwannomas of the vidian canal are an extremely rare type
of intracranial tumor with variable presentation. Symptoms
of vidian schwannomas can result from compression of
surrounding structures or extension into surrounding areas
that can cause headaches, facial pain and paresthesias, and
facial muscle paralysis. Dysfunction of the vidian nerve itself
may cause nasal dryness, decreased lacrimation, and corneal
desiccation. Herewe present an unusual case of a vidian nerve
schwannoma incidentally identiﬁed in a patient who was
asymptomatic from the lesion.
To date, four documented cases of biopsy-proven vidian
nerve schwannomas have appeared in the literature.
Reported cases include both male and female patients, rang-
ing in age from 13 to 78 years, with both unilateral and
bilateral lesions described.10–15 Presenting symptoms includ-
ed headache and facial palsy, oculomotor palsy and cerebro-
spinal ﬂuid leak, unilateral hearing loss secondary to
obstructive serous otitis media, and facial paresthesias. Com-
plete surgical resectionwas pursued for all four cases through
both open and endonasal approaches, although one patient
with bilateral vidian nerve schwannomas had only partial
resection of one lesion due to difﬁculties with surgical
access.13 All patients had signiﬁcantly improved or stable
symptoms, and the two patients with the most severe symp-
toms—one with oculomotor palsy and ptosis and the other
with headache and facial nerve palsy—demonstrated the
most dramatic postoperative improvement with near to
complete resolution of symptoms.10,13
Consistent with these cases, the traditional and curative
management of peripheral nerve tumors is surgical; recent
advancements in transnasal endoscopic skull base ap-
proaches frequently enable complete resection. Radiation
therapy by either SRS or multiple fraction radiotherapy is
also an alternative option for treatment. Conservative man-
agement through observation with serial imaging is also
reasonable when surgical resection is either not feasible or
involves a disproportionate risk of postsurgical morbidity
and/or mortality. The choice of treatment modality depends
on patient choice, functional status, presenting symptoms,
tumor location, tumor volume, and—in rare instances—ma-
lignant potential. The ultimate goal of both surgery and
radiotherapy is to maximize tumor control while also opti-
mizing preservation of surrounding structures.
In this case, the patient decided to pursue treatment with
radiation therapy. Conservative management was not consid-
ered, given the signiﬁcant increase in tumor volumeduring the
eight-year interval of MRI surveillance and the presence of
bone erosion. Given the rare presentation of a mass located in
the vidian canal, the decision was made to conﬁrm the
diagnosis with a biopsy prior to treatment. After histologic
conﬁrmation, the schwannoma was deemed favorable to be
controlled by radiation. The choice between single-fraction
SRS ormultiple-fraction radiationwasmade based on size and
proximity of the tumor to potential radiation-sensitive struc-
tures.Minimizing the riskof adverse effects from radiationwas
the determinant for pursuing fractionated radiation.
In recent years, radiation therapy has become a common
alternative to surgical resection of intracranial schwanno-
mas.16–21 Options include either single-fraction SRS or conven-
tional daily low-dose fractionation over approximately ﬁve
weeks. SRS is a well-tolerated procedure, typically completed
during a single session of irradiation and farmore convenient for
the patient. SRS has become awidely accepted treatment option
for vestibular schwannomas and has a high success rate of
durable tumor control with often partial reduction in tumor
volume,with progression-free survival of 93% at 5 years and 92%
at 10 years.22 Fractionated radiation has similar results and is
chosen over SRS when there is a concern that the size of target
Fig. 3 Intraoperative endoscopic views of biopsy using transsphe-
noidal approach. The mass (black arrow) is visible protruding from the
right vidian canal, located at the ﬂoor of the sphenoid sinus.
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exceeds safe tolerance to SRS, when there are critical radiation-
sensitive structures in adjacent areas that may not be able to
tolerate the single high-dose collateral exposure, or when there
are underlying concerns of the patient to suggest a higher risk of
an adverse event. Comparedwith surgery, radiation therapy has
been reported in several studies to result in decreasedmortality
and fewer treatment-related complications for vestibular
schwannoma including hearing loss and facial weakness.22–25
Recent advances in imaging and radiation delivery offer more
conformal treatment options such as SRT—which combines both
the superior accuracy of target localization of a stereotactic
system and reduction in the size of the radiation treatment
ﬁelds—and fractionated treatment, a radiobiologically safer
means of delivering radiation when there are concerns for late
effects of radiation decades after treatment completion.
Conclusion
Schwannomas of the vidian canal are extremely rare tumors
and may present with symptoms of headaches, facial pain,
facial muscle paralysis, decreased lacrimation, and nasal
dryness or as an incidental ﬁnding. When a vidian canal
tumor is identiﬁed, endoscopic biopsy can be used to conﬁrm
a histopathologically benign diagnosis before considering
treatment options. Treatment options include surgical resec-
tion and radiotherapy.
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